Transplanting stool from a healthy donor sounds like the kind of treatment that only exists in sensational headlines, but it’s a real therapy, already approved for certain gut infections, and in recent years it has started being tested against much more unexpected diseases, Parkinson’s among them. A new meta-analysis, published in Revista de Neurologia, reviewed all the available scientific evidence on this idea so far. The result calls for caution.
Why anyone would think of transplanting stool to treat Parkinson’s. The connection isn’t as far fetched as it sounds. There’s growing evidence that Parkinson’s is linked to the so called gut-brain axis, the constant communication between the bacteria living in our gut and the nervous system. People with Parkinson’s tend to have a different gut microbiota than the rest of the population, with fewer beneficial bacteria and more inflammation. That’s where the idea came from: replenishing those good bacteria through a fecal transplant (taking stool from a healthy donor and transplanting it into the patient’s gut) might slow or improve the disease’s symptoms.
What this study actually analyzed. A team of researchers from Loudi Central Hospital in China systematically reviewed, following the international PRISMA protocol with prior registration in the PROSPERO database, every randomized clinical trial published through September 2025 that tested fecal transplants in Parkinson’s patients. They found only five trials meeting the necessary quality criteria, with 226 participants total: 119 received the actual transplant and 107 received a placebo or standard care.
The results show no significant improvement. Researchers measured motor symptoms, daily living activities and cognitive abilities using standard medical scales (the MDS-UPDRS for motor symptoms, and the MoCA and MMSE tests for cognitive function). In none of these areas, at 4, 12 or 24 weeks of follow up, did the fecal transplant group improve in a statistically significant way compared to the control group.
There’s one nuance worth flagging. In the daily living activities score at 12 weeks, transplanted patients showed a trend toward improvement that came close to, without quite crossing, the usual threshold for statistical significance. The authors themselves describe it as a result inviting cautious optimism, not proof that the treatment works.
This doesn’t mean fecal transplants are a failure. The authors insist these negative results likely reflect how early this field of research still is, not that the idea itself has no future. Only five trials exist, with small samples, very different protocols from each other (some used frozen stool, others fresh; some delivered it via colonoscopy, others in capsules) and follow-up periods too short to detect changes that might take longer to appear. What is clear is that the procedure proved safe for patients.
Correlation, not causation, and that distinction matters here. If you’ve seen fecal transplants discussed online as a possible miracle cure for Parkinson’s, this scientific review is a good reminder of how science actually works: cautiously, without shortcuts, and without getting carried away by enthusiasm ahead of the evidence. For now, the available evidence doesn’t support its use as an effective treatment for Parkinson’s symptoms, though it doesn’t rule it out either. Larger trials with longer follow up are needed to know whether this therapy really has something to offer.
Source: Liang B, et al. “Systematic Review and Meta-Analysis of the Efficacy of Fecal Microbiota Transplantation in Parkinson’s Disease: An Exploration Based on UPDRS and Cognitive Scores.” Revista de Neurologia, 2026. DOI: 10.31083/RN50106.
